Surrozen (SRZN) Change in Receivables (2024 - 2026)

Surrozen (SRZN) recorded quarterly Change in Receivables of -$208000.0 in Q1 2026, up 89.8% quarter-over-quarter from -$2.0 million in Q4 2025.

Surrozen (SRZN) Change in Receivables (2024 - 2026) Analysis & Trends

Surrozen's Change in Receivables history runs 3 years deep, the most recent figure standing at -$208000.0 for Q1 2026.

  • In Q1 2026, Change in Receivables changed N/A year-over-year to -$208000.0; the TTM figure through Mar 2026 stood at -$2.2 million (down 547.61% YoY), while the FY2025 annual figure was -$2.0 million, down 506.18% from the prior year.
  • Change in Receivables was -$208000.0 for Q1 2026 at Surrozen, up from -$2.0 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $502000.0 in Q4 2024 to a low of -$2.0 million in Q4 2025.
  • Historically, Change in Receivables has averaged -$349000.0 across 3 years, with a median of -$208000.0 in 2026.
  • Biggest YoY gain for Change in Receivables was 506.18% in 2025; the steepest drop was 506.18% in 2025.
  • A 3-year view of Change in Receivables shows it stood at $502000.0 in 2024, then tumbled by 506.18% to -$2.0 million in 2025, then jumped by 89.8% to -$208000.0 in 2026.
  • The last three Change in Receivables figures came in at -$208000.0 (Q1 2026), -$2.0 million (Q4 2025), and $250000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 22,529.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -39.80 Mn
9 Abivax 94.37 Bn 94.37 Bn - -4.08 Mn
10 Surrozen 225,877.86 -106.68 Mn - -208,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -208,000.00
Mar 31, 2026 -208,000.00
Dec 31, 2025 -2.04 Mn
Dec 31, 2025 -2.04 Mn
Sep 30, 2025 250,000.00
Sep 30, 2025 250,000.00
Jun 30, 2025 -250,000.00
Jun 30, 2025 -250,000.00
Dec 31, 2024 502,000.00
Dec 31, 2024 502,000.00